Cargando…
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
BACKGROUND: There is a paucity of data regarding the prognostic influence of peripheral blood CD4+ T lymphopenia in non-small cell lung cancer (NSCLC). Therefore, we investigated the prognostic value of T lymphopenia in NSCLC. MATERIALS: Treatment-naive patients with a pathological diagnosis of NSCL...
Autores principales: | Eberst, Guillaume, Vernerey, Dewi, Laheurte, Caroline, Meurisse, Aurélia, Kaulek, Vincent, Cuche, Laurie, Jacoulet, Pascale, Almotlak, Hamadi, Lahourcade, Jean, Gainet-Brun, Marie, Fabre, Elizabeth, Le Pimpec-Barthes, Françoise, Adotevi, Olivier, Westeel, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092669/ https://www.ncbi.nlm.nih.gov/pubmed/35546670 http://dx.doi.org/10.1186/s12885-022-09628-8 |
Ejemplares similares
-
Distinct prognostic value of circulating anti-telomerase CD4(+) Th1 immunity and exhausted PD-1(+)/TIM-3(+) T cells in lung cancer
por: Laheurte, Caroline, et al.
Publicado: (2019) -
Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020) -
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
por: Mouillet, Guillaume, et al.
Publicado: (2018) -
Prevalence and Characteristics of Sleep Apnea in Intensive Care Unit Survivors After SARS-CoV-2 Pneumonia
por: Traore, Ibrahim, et al.
Publicado: (2022) -
Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia
por: Eberst, Guillaume, et al.
Publicado: (2022)